Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
European Medicines Agency concludes new advice to doctors and patients for Champix needed
Notice type:
Warning
Date:
14/12/2007
Product name or type:
Champix
Active Substance:
Varenicline
Problem Or Issue:
Following review at EU level, updated warnings for healthcare professionals and patients are necessary to increase awareness of cases of suicidal ideation and suicide attempt in patients using Champix, indicated for smoking cessation in adults.
Background Information Or Related Documents:
European Medicines Agency concludes new advice to doctors and patients for Champix needed Document
Further Information:
For further information, click
here
« Back
Date Printed: 11/05/2024